Page last updated: 2024-12-07

4-bromophenylboric acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

4-Bromophenylboric acid is an organoboron compound with the formula C6H4BrB(OH)2. It is a white solid that is soluble in water. The compound is a versatile reagent in organic synthesis, finding use in Suzuki-Miyaura cross-coupling reactions for the formation of carbon-carbon bonds. Its synthesis typically involves the reaction of 4-bromophenylmagnesium bromide with trimethyl borate followed by hydrolysis. 4-Bromophenylboric acid is studied extensively due to its importance as a building block in the synthesis of pharmaceuticals, agrochemicals, and materials. Its reactivity with various electrophiles allows for the creation of diverse structures with specific functionalities. The compound's ability to undergo palladium-catalyzed coupling reactions makes it a valuable tool in the development of new drugs and materials.'

Cross-References

ID SourceID
PubMed CID79599
CHEMBL ID20866
SCHEMBL ID24700
MeSH IDM0111448

Synonyms (66)

Synonym
4-16-00-01668 (beilstein handbook reference)
para-bromophenylboric acid
nsc25407
benzeneboronic acid, p-bromo-
4-bromobenzeneboronic acid
5467-74-3
p-bromobenzeneboronic acid
4-bromophenylboric acid
wln: qbqr de
(p-bromophenyl)boronic acid
p-bromophenylboric acid
boronic acid, (4-bromophenyl)-
nsc-25407
(4-bromophenyl)boronic acid
einecs 226-779-9
dihydroxy-4-bromophenylborane
ai3-32763
nsc 25407
brn 2936347
p-bromophenylboronic acid
4-bromophenylboronic acid, >=95.0%
NCGC00092014-01
4-bromophenylboronic acid ,
B1858 ,
4-bromo phenyl boronic acid
CHEMBL20866 ,
4-bromophenyl boronic acid
bdbm50067892
AKOS002679425
A7938
NCGC00092014-02
4-bromo-phenylboronic acid
EN300-74359
FT-0600740
AM20060339
AB00202
RB3087
SCHEMBL24700
AS-2310
4-bromo-benzeneboronic acid
4-bromobenzene boronic acid
4-bromo-phenyl-boronic acid
p-bromo phenylboronic acid
(4-bromophenyl) boronic acid
4bromophenylboronic acid
4bromobenzene boronic acid
p-bromophenyl boronic acid
SY013412
mfcd00002104
4-bromophenylboronic acid #
W-105610
4-bromophenylboronic
AC-24813
boronic acid, b-(4-bromophenyl);4-bromophenylboronic acid
DTXSID90203129
CS-W008847
4-bromo phenylboronic acid
4-bromophenylboronic acid (contains varying amounts of anhydride)
Q63398883
isoferulicacid
boronic acid,b-(4-romophenyl);4-bromophenylboronic acid
OL10116
(4-bromophenyl)boronicacid
4-bromophenylboronic acid-d4 (contains varying amounts of anhydride)
PD182103
Z1169350731
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (8)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Ferritin light chainEquus caballus (horse)Potency25.11895.623417.292931.6228AID485281
TDP1 proteinHomo sapiens (human)Potency35.48130.000811.382244.6684AID686978
thyroid stimulating hormone receptorHomo sapiens (human)Potency6.30960.001318.074339.8107AID926; AID938
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Beta-lactamaseEscherichia coli K-12Ki3.60000.02703.64137.3000AID38398
Carbonic anhydrase 1Homo sapiens (human)Ki11.70000.00001.372610.0000AID424442
Carbonic anhydrase 2Homo sapiens (human)Ki7.00000.00000.72369.9200AID424443
Angiotensin-converting enzymeRattus norvegicus (Norway rat)Ki3.60000.00011.96427.3000AID38398
Carbonic anhydraseCandida albicans SC5314Ki15.90000.01051.44448.3470AID424445
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (14)

Processvia Protein(s)Taxonomy
antibiotic catabolic processBeta-lactamaseEscherichia coli K-12
response to antibioticBeta-lactamaseEscherichia coli K-12
one-carbon metabolic processCarbonic anhydrase 1Homo sapiens (human)
morphogenesis of an epitheliumCarbonic anhydrase 2Homo sapiens (human)
positive regulation of synaptic transmission, GABAergicCarbonic anhydrase 2Homo sapiens (human)
positive regulation of cellular pH reductionCarbonic anhydrase 2Homo sapiens (human)
angiotensin-activated signaling pathwayCarbonic anhydrase 2Homo sapiens (human)
regulation of monoatomic anion transportCarbonic anhydrase 2Homo sapiens (human)
secretionCarbonic anhydrase 2Homo sapiens (human)
regulation of intracellular pHCarbonic anhydrase 2Homo sapiens (human)
neuron cellular homeostasisCarbonic anhydrase 2Homo sapiens (human)
positive regulation of dipeptide transmembrane transportCarbonic anhydrase 2Homo sapiens (human)
regulation of chloride transportCarbonic anhydrase 2Homo sapiens (human)
carbon dioxide transportCarbonic anhydrase 2Homo sapiens (human)
one-carbon metabolic processCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (8)

Processvia Protein(s)Taxonomy
beta-lactamase activityBeta-lactamaseEscherichia coli K-12
hydrolase activityBeta-lactamaseEscherichia coli K-12
arylesterase activityCarbonic anhydrase 1Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 1Homo sapiens (human)
protein bindingCarbonic anhydrase 1Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 1Homo sapiens (human)
hydro-lyase activityCarbonic anhydrase 1Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 1Homo sapiens (human)
arylesterase activityCarbonic anhydrase 2Homo sapiens (human)
carbonate dehydratase activityCarbonic anhydrase 2Homo sapiens (human)
protein bindingCarbonic anhydrase 2Homo sapiens (human)
zinc ion bindingCarbonic anhydrase 2Homo sapiens (human)
cyanamide hydratase activityCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (8)

Processvia Protein(s)Taxonomy
outer membrane-bounded periplasmic spaceBeta-lactamaseEscherichia coli K-12
periplasmic spaceBeta-lactamaseEscherichia coli K-12
cytosolCarbonic anhydrase 1Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 1Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
cytosolCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
myelin sheathCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
extracellular exosomeCarbonic anhydrase 2Homo sapiens (human)
cytoplasmCarbonic anhydrase 2Homo sapiens (human)
plasma membraneCarbonic anhydrase 2Homo sapiens (human)
apical part of cellCarbonic anhydrase 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (11)

Assay IDTitleYearJournalArticle
AID424444Inhibition of Cryptococcus neoformans recombinant Carbonic anhydrase 2 pre-incubated for 15 mins by CO2 hydration stopped-flow assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
AID424442Inhibition of human recombinant cytosolic carbonic anhydrase 1 preincubated for 15 mins by CO2 hydration stopped-flow assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
AID38398Inhibitory activity against Escherichia coli AmpC beta-lactamase.1998Journal of medicinal chemistry, Nov-05, Volume: 41, Issue:23
Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
AID493709Inhibition of synthetic melanin polymerization after 30 to 60 mins by UV-vis spectroscopic analysis2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Aryl boronic acid inhibition of synthetic melanin polymerization.
AID1127999Cytotoxicity against human KB cells assessed growth inhibition at 10 uM after 72 hrs by MTS assay2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID424445Inhibition of Candida albicans recombinant Carbonic anhydrase pre-incubated for 15 mins by CO2 hydration stopped-flow assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
AID1127992Inhibition of NorA in fluoroquinolone-resistant Staphylococcus aureus 1199B assessed as potentiation of 4 ug/ml of ciprofloxacin MIC at 100 ug/ml after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID1127996Toxicity in fluoroquinolone-resistant Staphylococcus aureus 1199B expressing NorA after 24 hrs by microdilution method2014Journal of medicinal chemistry, Mar-27, Volume: 57, Issue:6
First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
AID493710Inhibition of synthetic melanin polymerization at 2 mM after 30 to 60 mins by UV-vis spectroscopic analysis relative to control2010Bioorganic & medicinal chemistry letters, Aug-01, Volume: 20, Issue:15
Aryl boronic acid inhibition of synthetic melanin polymerization.
AID424443Inhibition of human recombinant cytosolic carbonic anhydrase 2 preincubated for 15 mins by CO2 hydration stopped-flow assay2009Bioorganic & medicinal chemistry letters, May-15, Volume: 19, Issue:10
Carbonic anhydrase inhibitors. Inhibition of the fungal beta-carbonic anhydrases from Candida albicans and Cryptococcus neoformans with boronic acids.
AID1802941Urease Inhibition Assay from Article 10.3109/14756360903468155: \\Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids.\\2010Journal of enzyme inhibition and medicinal chemistry, Oct, Volume: 25, Issue:5
Inhibition studies of soybean (Glycine max) urease with heavy metals, sodium salts of mineral acids, boric acid, and boronic acids.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (12.50)18.7374
1990's3 (37.50)18.2507
2000's1 (12.50)29.6817
2010's3 (37.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.47

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.47 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.47)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]